U.S. Medical Equipment Stock News

Apollo Global Management (APO) has been in focus after Apollo managed funds agreed to invest US$1.0 billion alongside Realty Income in a joint venture owning roughly 500 single-tenant, long-lease retail properties. See our latest analysis for Apollo Global Management. At a share price of US$112.0, Apollo’s recent 7 day share price return of 7.24% has come after a 90 day share price decline of 24.78%, while its 5 year total shareholder return of 166.66% points to strong longer term...

Alumis reported full-year 2025 results showing US$24.05 million in revenue and a net loss of US$243.33 million, while also filing a universal shelf registration and a US$300 million at-the-market follow-on equity offering alongside positive Phase 3 topline data for its TYK2 inhibitor envudeucitinib in plaque psoriasis. By pairing encouraging late-stage clinical data and plans for a 2026 New Drug Application with expanded financing flexibility, Alumis is signaling a push to advance...

Recent investor commentary has brought fresh attention to HEICO (HEI), after fund managers highlighted its volume growth compared with aerospace peers, continued margin expansion, and strong free cash flow, all tied to supply chain constraints and higher maintenance demand. See our latest analysis for HEICO. Despite HEICO's operational strengths gaining attention, the recent share price tells a different story, with a 1 month share price return of a 21.75% decline and a year to date share...

Sanmina (SANM) is drawing attention after recent share price moves, with the stock showing a 5.7% total return over the past year, along with multi-year gains and weaker performance in the past month. See our latest analysis for Sanmina. The recent 1 month share price decline of 17.0% and 1 day move of 5.7% lower sit in sharp contrast to a 1 year total shareholder return of 56.9%. This suggests longer term momentum while near term sentiment has cooled. If Sanmina's recent swing has you...

If you are wondering whether Intuitive Surgical at around US$477.97 is a bargain or already pricing in high expectations, you are not alone. The stock has returned 1.2% over the last 7 days, after a 5.2% decline over 30 days and a 14.9% decline year to date, while the 1 year return sits at a 2.9% decline and the 3 and 5 year returns are 86.4% and 96.2% respectively. Recent coverage has focused on how Intuitive Surgical fits into longer term themes in medical technology and how sentiment has...

PitchBook, a Morningstar subsidiary, was named one of G2's top-rated financial services software products for 2026, reflecting customer driven ratings. Morningstar (NasdaqGS:MORN) announced the winners of its UK Awards for Investing Excellence, recognising firms and funds for investment research and stewardship in the UK market. For you as an investor, these updates highlight different sides of Morningstar’s business, from software and data through PitchBook to research and ratings under...

Opera (NasdaqGS:OPRA) and Celo have agreed a restructured, multi year partnership that makes Opera a major network stakeholder in the Celo ecosystem. The deal centers on MiniPay and a planned push to drive global stablecoin usage across up to 50 million Opera users. The partnership includes a 160 million CELO allocation, expansion of MiniPay into new markets, and grassroots roadshows to support user adoption. Opera, trading at $14.36, now ties a bigger part of its fintech plans to the Celo...

The sharp recent move in Hims & Hers Health (HIMS) comes after Novo Nordisk agreed to resume selling its weight loss drugs on the platform, ending a public legal dispute and restoring their commercial relationship. See our latest analysis for Hims & Hers Health. The renewed Novo Nordisk agreement and the appointment of a new Chief Communications Officer come after a volatile stretch, with a 40.88% 1 month share price return followed by a 37.18% 3 month share price decline and a 36.63% 1 year...

Earlier this week, US President Donald Trump and Japanese Prime Minister Sanae Takaichi announced a joint US–Japan energy investment plan in which GE Vernova and Hitachi will develop BWRX-300 small modular nuclear reactors in Tennessee and Alabama, alongside Japanese-backed natural gas power projects in Pennsylvania and Texas. This government-supported partnership could reshape GE Vernova’s long-term project pipeline by tying its nuclear and gas technologies directly to rising electricity...

Farmers National Banc (FMNB) has recently drawn investor attention after a period in which the share price showed mixed short-term performance, including a loss of 7.4% over the past month. See our latest analysis for Farmers National Banc. The recent 7.4% 1 month share price return decline and 9.2% 3 month share price return decline contrast with a 2.0% 1 year total shareholder return. This suggests that momentum has cooled even as longer term holders remain modestly ahead. If this kind of...

Wondering if Hess Midstream at around US$39.59 is still offering value, or if most of the easy gains are already on the table. The stock has returned 1.5% over the last 7 days, 4.5% over the last 30 days, 14.3% year to date and 0.4% over the past year, with very large returns over the past 3 and 5 years of 85.1% and 173.4% respectively. Recent coverage has focused on Hess Midstream's role as a midstream infrastructure provider and how that positions the company within the broader energy...

Tidewater stock snapshot after recent moves Tidewater (TDW) has drawn investor attention after a recent pullback, with the share price down 2.4% on the day and 5.6% over the past week, despite strong 1 year and 3 year total returns. See our latest analysis for Tidewater. The recent 1 day and 7 day share price declines sit against a much stronger backdrop, with a 90 day share price return of 41.42% and a 1 year total shareholder return of 72.28%, suggesting momentum has cooled slightly after a...

Investors may be wondering whether Signet Jewelers, at around US$89 per share, still offers good value after a strong run, or if the current price already reflects most of the potential upside. The stock has returned 8.3% over the last 7 days, while the 30 day return is a 9.1% decline and the 1 year return is 55.8%. These moves may leave you questioning whether the recent swings signal opportunity or shifting risk. Recent coverage has focused on Signet Jewelers as a Specialty Retail name...

Event context and recent share performance monday.com (MNDY) has been drawing investor attention after a period of weak share performance, with the stock showing negative returns over the past month, past 3 months, year to date, and past year. Against that backdrop, investors are reassessing how the company’s US$1.23b in revenue and US$118.74m in net income align with its current market value of about US$3.75b and its recent value score of 2. See our latest analysis for monday.com. With the...

Wondering if Innospec, at around its recent US$65.89 close, is offering value or a value trap? This review breaks down what the current share price really reflects. The stock has recently seen a 4% decline over the past week, an 18.9% decline over the past month, and a 29.9% decline over the last year, which may signal that the market is reassessing both growth potential and risk. Recent coverage of Innospec has focused on its position within the chemicals sector and how investors are...

Wondering whether SentinelOne at around US$14.17 is starting to look like value or still carries a premium, especially after a weak year for the share price. The stock has slipped around 2.4% over the last week but is up about 9.3% over the last month, while the 1 year return sits at roughly 26.5% in the red and the year to date performance is around 3.2% lower. Recent coverage has focused on how investors are reassessing cybersecurity names in light of shifting risk sentiment and renewed...

Boston Scientific (NYSE:BSX) is expanding its urology business in EMEA through the acquisitions of Axonics and Valencia Technologies. The deal broadens patient access to sacral neuromodulation treatments for bladder and bowel disorders across the region. The Axonics F15 rechargeable free system is part of the expanded portfolio targeting bladder and faecal incontinence. For investors following Boston Scientific at a share price of $69.48, this move adds a fresh angle to a company often...

Why Agnico Eagle Mines Is On Investors’ Radar Today Agnico Eagle Mines (NYSE:AEM) has drawn attention after recent share price pressure, with the stock showing negative returns over the past week, month and past 3 months. This has prompted investors to reassess its current valuation and fundamentals. See our latest analysis for Agnico Eagle Mines. While the recent 1 month share price return of negative 21.52% suggests momentum has cooled in the short term, the 1 year total shareholder return...

Welltower (NYSE:WELL) closed and upsized a US$6.25b revolving credit facility, securing revised terms. The facility adjustment extends the company’s debt maturity profile and provides additional funding flexibility. Moody's revised its credit rating outlook on Welltower to positive from stable following this financing step. For investors following healthcare real estate, Welltower is an important player in senior housing and medical facilities, areas tied to long term demographic trends...

Albemarle completed a debt tender offer, increasing its repurchase cap from $500 million to $650 million after strong investor interest. The company also filed an omnibus shelf registration covering a range of potential securities for future capital raising. These moves highlight active balance sheet management and add flexibility for funding future initiatives. For investors watching NYSE:ALB, these capital moves sit alongside a share price of $156.7 and a 1 year return of 105.6%. Over 3...

Morgan Stanley recently elevated Intuit to its Top Pick list, pointing to the company’s broad-based strength following past quarterly results and growing confidence in product cycles that could support a more robust long-term growth profile. The bank also flagged Intuit’s upcoming tax-season and fiscal 2026 outlook updates as important catalysts, especially for understanding the trajectory of Assisted Tax and Mid-Market Accounting & Services. We’ll now examine how Morgan Stanley’s Top Pick...

Investors may be wondering whether Skyward Specialty Insurance Group's current share price still reflects good value, or if most of the opportunity is already priced in. The stock recently closed at US$41.26, with an 8.7% decline over 7 days, a 10.0% decline over 30 days, a 15.1% decline year to date and a 17.1% decline over 1 year, while the 3-year return stands at a gain of 108.0%. Recent coverage has focused on how the share price performance contrasts with that longer-term track record...

Archer Aviation (NYSE:ACHR) has announced that Chief Administrative Officer Tosha Perkins is transitioning into a senior advisor role. The change affects one of the company’s key C-suite positions, with Perkins expected to continue supporting leadership in an advisory capacity. For investors watching Archer Aviation at a current share price of $5.76, this leadership shift comes after a period of mixed share performance. The stock shows a 128.6% return over 3 years, along with declines of...

Catastrophe losses put Allstate (ALL) risk exposure in focus Allstate (ALL) recently reported estimated February catastrophe losses of $140 million, or $111 million after tax, bringing January and February catastrophe losses to $315 million, or $249 million after tax. For you as a shareholder or potential investor, these figures highlight how weather and other catastrophic events can influence near term earnings, capital allocation decisions and views on the insurer's overall risk...